SCN8A p.Arg1620Gln
Variant summary
The NM_001330260.2(SCN8A):c.4859G>A (p.Arg1620Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The gene SCN8A is a cancer driver gene (CancerMine: 1 driver citations). The variant allele was found at a cumulative frequency of 0.000000707 (AC=1) in the gnomAD database across 1,415,192 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000092. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 10.00). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R1620P: Pathogenic (ClinVar VariationId 4812133, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R1620*: Uncertain_significance (ClinVar VariationId 2784669, 1 star)
Frequency
Consequence
NM_001330260.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
- developmental and epileptic encephalopathy, 13Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- cognitive impairment with or without cerebellar ataxiaInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- seizures, benign familial infantile, 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonus, familial, 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000001, AC = 1 — absent/extremely rare (O3 moderate [+2]) | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 18 pathogenic, 0 benign (OR vs. background: 185.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 10.45 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_001330260.2. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SCN8A | MANE Select | c.4859G>A p.Arg1620Gln | missense | Exon 27 of 27 | Prot: NP_001317189.1 UniProt: | |
SCN8A | MANE Plus Clinical | c.4859G>A p.Arg1620Gln | missense | Exon 27 of 27 | Prot: NP_055006.1 UniProt: | |
SCN8A | c.4736G>A p.Arg1579Gln | missense | Exon 26 of 26 | Prot: NP_001171455.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SCN8A | TSL:1MANE Plus Clinical | c.4859G>A p.Arg1620Gln | missense | Exon 27 of 27 | Prot: ENSP00000346534.4 UniProt: | |
SCN8A | TSL:5MANE Select | c.4859G>A p.Arg1620Gln | missense | Exon 27 of 27 | Prot: ENSP00000487583.2 UniProt: | |
SCN8A | TSL:5 | c.4892G>A p.Arg1631Gln | missense | Exon 26 of 26 | Prot: ENSP00000476447.3 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | AF: 7.07e-7 | AC:1 | Hom:0 | AN:1415192 | Cov:33 |
GnomAD4 genome | Cov:32 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 30 | |
AlphaMissense | Pathogenic | 0.98 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.58 | |
CADD | Pathogenic | 29 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Pathogenic | 0.97 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 1.0 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -9.5 | |
GPN-Star score | N/A | 9.5 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.89 | D |
MetaRNN | Pathogenic | 0.98 | D |
MetaSVM | Pathogenic | 1.1 | D |
Mutation Taster | N/A | 11/89 | disease causing |
MutationAssessor | Pathogenic | 4.3 | H |
PhyloP100 | Pathogenic | 10 | |
popEVE | Pathogenic | -5.9 | |
PrimateAI | Pathogenic | 0.88 | D |
PROVEAN | Uncertain | -3.6 | D |
REVEL | Pathogenic | 0.92 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Uncertain | 0.0020 | D |
Varity_R | N/A | 0.90 | |
VESM-3B | Benign | -14 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.